Price target upside
Context Therapeutics Inc. Price Target Upside or Downside
CNTX price target upside based on the current price and analyst average.
Direct answer
Context Therapeutics Inc.'s analyst target implies +804.7%.
The average target is $4.25 compared with a recorded current price of $0.47.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 13, 2026.
Get free Context Therapeutics Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.47
- Average price target
- $4.25
- High price target
- $6.00
- Low price target
- $2.00
- Target upside
- +804.7%
- Consensus rating
- Strong Buy
- Analysts
- 9
- Evidence date
- August 13, 2026
- Valid through
- August 20, 2026